About Us
News
Therini Bio Secures $17 Million Investment to Advance Fibrin Therapeutic Candidates Towards the Clinic
SOUTH SAN FRANCISCO, Calif, May 10, 2021 /PRNewswire/ -- Therini Bio, Inc. announced it has completed an oversubscribed Seed Extension round of financing. The capital will accelerate the development of Therini's lead program – a monoclonal antibody against fibrin –...
MedaRed Announces Name Change to Therini Bio
Corporate Headquarters Relocated to Lilly Gateway Labs in South San FranciscoNEWS PROVIDED BYTherini Bio, Inc.Feb 24, 2020, 08:17 ET SOUTH SAN FRANCISCO, Calif., Feb. 24, 2020 /PRNewswire/ -- MedaRed, Inc., a vascular biology company focused initially on discovering...
MedaRed Raises $6.5 Million and Appoints Industry Leaders to Board of Directors, Top Management Roles
Daniel Burgess and Jeffrey Stavenhagen, PhD join leadership team NEWS PROVIDED BY MedaRed, Inc.Jul 08, 2019, 08:00 ET SAN FRANCISCO, July 8, 2019 /PRNewswire/ -- MedaRed, Inc., a biotechnology company focused on discovering and developing new therapeutics targeting...